Liver fat study in type 1 diabetes
Part of Digestive system, Hormones & metabolism, Immune system & allergy clinical trials.
This trial looks at how common fatty liver disease is in people with type 1 diabetes. Doctors will check your liver with tests to learn more and find out if you might be at risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes.
- You are 18 years old or older.
- You are willing to sign a consent form to join the study.
- You do not drink too much alcohol.
- You do not have other liver diseases or conditions that cause fat in the liver.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common fatty liver disease is in people with type 1 diabetes and what might increase the risk. By joining, you could help doctors understand and better manage liver health for people with type 1 diabetes.
This study looks at blood cells and factors in people with metabolic diseases like fatty liver, prediabetes, or type 2 diabetes. It aims to better understand these conditions by comparing them with healthy volunteers.
This study looks at people with fatty liver disease and common health issues like obesity, diabetes, high blood pressure, or abnormal cholesterol. It may help researchers understand how liver fat and heart/metabolism problems relate and how they affect health over time.
This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.
This study looks at how fat tissue works differently in people with type 1 diabetes who have extra belly fat, and how that may lead to fat building up in the liver. It compares them to people without diabetes to better understand the link.
This study is looking for people with type 2 diabetes and fatty liver disease to find better ways to track how the disease progresses. They will use special tests (biomarkers) to see if the liver is getting worse over time.
Hear when a new NAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.